SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-270039
Filing Date
2022-10-27
Accepted
2022-10-26 21:59:04
Documents
16
Period of Report
2022-10-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d374961d8k.htm   iXBRL 8-K 30915
2 EX-1.1 d374961dex11.htm EX-1.1 225570
3 EX-4.1 d374961dex41.htm EX-4.1 66725
4 EX-5.1 d374961dex51.htm EX-5.1 11972
8 GRAPHIC g374961g1026133624269.jpg GRAPHIC 2534
  Complete submission text file 0001193125-22-270039.txt   543699

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20221025.xsd EX-101.SCH 2858
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20221025_lab.xml EX-101.LAB 17996
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20221025_pre.xml EX-101.PRE 11263
10 EXTRACTED XBRL INSTANCE DOCUMENT d374961d8k_htm.xml XML 3344
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 221334691
SIC: 2836 Biological Products, (No Diagnostic Substances)